Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.01T, Eli Lilly(LLY) trades at $1,068.87. The stock has a price-to-earnings ratio of 38.95 and currently yields dividends of 59.7%.
On 2026-06-02, Eli Lilly(LLY) stock moved within a range of $1,052.15 to $1,082.00. With shares now at $1,068.87, the stock is trading +1.6% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 731.09K, compared to an average daily volume of 3.25M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.
LLY News
The key to understanding the investment case for Viking Therapeutics (VKTX 4.89%) stock lies in the benefits of having a weight-loss drug, namely VK2735, in dev...
Eli Lilly (LLY) and Company announced the details of presentations at the European Hematology Association Annual Meeting, taking place June 11-14 in Stockholm,...
Eli Lilly (NYSE:LLY) reported landmark Phase 3 results for Retevmo as adjuvant therapy in early-stage RET fusion-positive non-small cell lung cancer. The LIBRE...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly (LLY) has signed a $1.26 billion licensing agreement to develop, manufacture, and commercialize a new intestinal treatment for South Korea’s Hanmi Pha...
The deals come as investors also evaluate positive Phase 3 data for Lilly's cancer therapy Retevmo, even as the stock traded lower in Monday's premarket session...
Camurus (CAMRF) announced that Eli Lilly (LLY) has exercised its option to include amylin receptor agonists in the collaboration and license agreement entered i...
Eli Lilly Growing at 55% as a Trillion-Dollar Company: ‘These Are NVIDIA-Like Growth Numbers’ By Thomas Richmond Published Jun 1, 11:35AM EDT Quick Read Macro...
Key Points Eli Lilly recently won approval of a new product, strengthening its weight loss portfolio. The pharma giant has become the leader in the U.S. GLP-1...
Eli Lilly recently reported extensive Phase 3 data for its obesity and diabetes pipeline at the American Diabetes Association meeting, highlighted by retatrutid...
Key Points The market for GLP-1 drugs is large and attractive, with Eli Lilly currently an industry leader. Competition in the drug industry is fierce, with E...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.